|
Volumn 51, Issue 19, 2015, Pages 3973-3976
|
A metal-based tumour necrosis factor-alpha converting enzyme inhibitor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CHLOROTRIANISENE;
IRIDIUM COMPLEX;
IRIDIUM(III) COMPLEX 1;
MITOGEN ACTIVATED PROTEIN KINASE P38;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;
UNCLASSIFIED DRUG;
ADAM PROTEIN;
IRIDIUM;
ORGANOMETALLIC COMPOUND;
PROTEINASE INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;
ARTICLE;
CELL DIFFERENTIATION;
CELL FREE SYSTEM;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DENSITY FUNCTIONAL THEORY;
DISSOCIATION CONSTANT;
DRUG MECHANISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME PHOSPHORYLATION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
LEUKEMIA CELL LINE;
MONOCYTIC LEUKEMIA;
PROTEIN CLEAVAGE;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
PROTEIN PROTEIN INTERACTION;
PROTON NUCLEAR MAGNETIC RESONANCE;
ANTAGONISTS AND INHIBITORS;
CELL LINE;
CHEMISTRY;
DRUG EFFECTS;
METABOLISM;
MONOCYTE;
PHOSPHORYLATION;
SECRETION (PROCESS);
ADAM PROTEINS;
CELL LINE;
HUMANS;
IRIDIUM;
MONOCYTES;
ORGANOMETALLIC COMPOUNDS;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHORYLATION;
PROTEASE INHIBITORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84923323824
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c4cc09251a Document Type: Article |
Times cited : (26)
|
References (51)
|